Liquidity is under pressure as evidenced by a negative 6.8% free cash flow margin in 2026Q3 and a dwindling cash balance of $38.1 million.
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 |
|---|
| Cash from Operations | -19.12M | 2.86M | -11.9M | 15.54M | -2.4M | 38.51M | -1.47M | -29.64M | 18.33M | -380K | 33.54M | -16.73M | 346K | -66.18M | -38.28M | 12.4M | -5.07M | -8.05M | -17.99M | 11.6M | 25.5M | 18.02M |
| Operating CF Margin % | - | 0.62% | -2.67% | 3.47% | -0.56% | 9.72% | -0.38% | -7.08% | 4.53% | -0.1% | 8.41% | -4.41% | 0.09% | -20.94% | -9.35% | 5.58% | -2.29% | -3.44% | -8.55% | 8.26% | 48.22% | 80.51% |
| Operating CF Growth % | -1049.89% | 124.03% | -176.61% | 747.46% | -106.23% | 2721.65% | 95.04% | -261.7% | 4923.95% | -101.13% | 300.43% | -4936.13% | 100.52% | -72.88% | -408.63% | 344.49% | 36.95% | 55.27% | -255.12% | -54.53% | 41.58% | - |
| Net Income | -46.13M | -1.59M | -15.54M | -9.28M | -5.35M | -6.31M | 3.83M | -16.43M | -23.9M | -29.58M | -25.5M | -40.21M | -35.45M | -116.51M | -78.45M | -27.11M | 2.84M | 609K | 5.38M | -5.62M | -33.69M | -25.19M |
| Depreciation & Amortization | 7.51M | 6.15M | 5.91M | 4.53M | 5.51M | 6.39M | 7.54M | 10.49M | 9.73M | 18.04M | 18.3M | 19.49M | 20.56M | 25.56M | 32.59M | 7.57M | 7.12M | 6.65M | 7.69M | 6.25M | 3.81M | 2.08M |
| Stock-Based Compensation | 6.71M | 10.2M | 9.48M | 10.05M | 10.6M | 9.33M | 8.15M | 10.6M | 12.29M | 13.63M | 12.64M | 13.93M | 11.31M | 8.22M | 8.46M | 13.37M | 10.23M | 15.46M | 16.9M | 12.63M | 0 | 0 |
| Deferred Taxes | 80K | 156K | 1.4M | 456K | 1.78M | -114K | 353K | -86K | 30K | -268K | -404K | 664K | 92K | 947K | 1.69M | 524K | 260K | 705K | -16.72M | 553K | 0 | 0 |
| Other Non-Cash Items | 13.44M | 6.15M | 8.77M | 5.16M | 7.65M | 21.42M | 538K | 12.5M | 10.13M | 10.28M | 12.54M | 11.32M | 10.89M | 26.63M | 5.72M | 1.7M | 684K | 3.1M | 17.82M | -335K | 9M | 9.14M |
| Working Capital Changes | -736K | -18.2M | -21.92M | 4.62M | -22.6M | 7.8M | -21.88M | -46.72M | 10.04M | -12.49M | 15.97M | -21.93M | -7.07M | -11.03M | -8.29M | 16.36M | -26.21M | -34.57M | -49.05M | -1.88M | 46.4M | 31.98M |
| Change in Receivables | 12.61M | 13.36M | -15.83M | 18.49M | -12.52M | 5.24M | 19.03M | -46.16M | 7.22M | -15.73M | 22.95M | -8.33M | -14.79M | 10.86M | -9.16M | 8.7M | -2.45M | -2.82M | -23.92M | -936K | 0 | 0 |
| Change in Inventory | -15.11M | -9.11M | -4M | -6.86M | -22.86M | 1.69M | -23.18M | -14.16M | -8.69M | 7.67M | -10.5M | -21.09M | -8.34M | -5.15M | 11.93M | -4.32M | 244K | -9.68M | -10.43M | -8.77M | -4.35M | -2.29M |
| Change in Payables | 6.78M | -18.67M | 17.36M | 2.85M | 11.68M | -3.98M | -6.77M | 9.46M | 2M | 2.19M | 2.4M | -1.82M | -1.06M | -1.14M | -21.43M | 10.66M | -5.36M | 1.83M | -1.18M | 9.53M | 0 | 0 |
| Cash from Investing | -14.33M | -8.52M | -3.6M | -12.68M | -4.72M | -2.4M | -3.73M | -4.31M | 17.77M | 17.82M | 8.26M | 3.69M | 8.49M | -121.62M | -12.15M | 31.42M | 10.53M | 1.87M | -133.42M | -7.51M | -12.45M | -12.27M |
| Capital Expenditures | -6.72M | -4.27M | -3.6M | -12.61M | -4.72M | -2.32M | -3.56M | -4.31M | -6.61M | -5.36M | -8.07M | -10.45M | -11.93M | -15.36M | -10.77M | -4.02M | -5.13M | -4.23M | -5.03M | -7.23M | -13.6M | -6.25M |
| CapEx % of Revenue | 1.57% | 0.93% | 0.81% | 2.82% | 1.1% | 0.59% | 0.93% | 1.03% | 1.63% | 1.4% | 2.02% | 2.75% | 3.23% | 4.86% | 2.63% | 1.81% | 2.31% | 1.81% | 2.39% | 5.15% | 25.71% | 27.93% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -79K | 0 | 0 | 333K | 333K | 0 | 0 | 0 | -3.86M | -1.38M | -70.27M | 0 | 0 | 0 | 0 | 0 | -5.61M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -7.61M | -4.25M | 0 | -67K | 0 | -389K | -170K | 0 | -333K | -333K | 16.33M | 14.13M | 20.42M | -232K | 0 | 0 | 0 | 4.3M | -4.83M | 1K | 1.16M | -153K |
| Cash from Financing | -2.49M | -4.25M | -3.95M | -2.11M | -15.37M | -28.8M | 26.7M | 28.47M | -27.45M | -54.54M | -757K | 5.89M | 8.38M | 117.92M | 100.55M | 5.6M | 3.84M | 5.78M | -16.25M | 172.86M | -2.25M | 1.56M |
| Debt Issued (Net) | 9.9M | 7.5M | -6M | -3.87M | -19M | -17.41M | 24.45M | 24.55M | -31.55M | -56.91M | -1.77M | 0 | -417K | 110.46M | 96.1M | 0 | 0 | 0 | 0 | 0 | -3M | 0 |
| Equity Issued (Net) | 1.29M | 1.63M | 2.25M | 2.2M | 3.89M | -14.42M | 0 | 3.93M | 0 | 0 | 3.85M | 6.55M | 9.05M | 7.46M | 4.45M | 5.6M | 2.03M | 4.11M | -16.67M | 172.31M | 748K | 1.56M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -14.08M | 0 | 0 | -293K | -1.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23.98M | 0 | -21K | -177K |
| Other Financing | -13.68M | -13.38M | -198K | -447K | -258K | 3.03M | 2.24M | 0 | 4.1M | 2.37M | -2.83M | -660K | -260K | 0 | 0 | 0 | 1.81M | 1.67M | 419K | 553K | 0 | 0 |
| Net Change in Cash | -35.79M | -8.26M | -20.81M | 1.05M | -28.05M | 8.29M | 21.73M | -5.36M | 8.3M | -36.9M | 40.22M | -12.79M | 19.03M | -70.19M | 47.6M | 50.47M | 8.6M | -101K | -167.89M | 176.97M | 10.83M | 7.3M |
| Free Cash Flow | -28.95M | -5.66M | -15.51M | 2.86M | -7.12M | 36.19M | -5.2M | -33.95M | 11.72M | -5.74M | 25.47M | -27.18M | -11.59M | -81.53M | -49.05M | 8.38M | -10.2M | -12.28M | -23.02M | 4.37M | 11.9M | 11.77M |
| FCF Margin % | -6.76% | -1.24% | -3.47% | 0.64% | -1.66% | 9.13% | -1.36% | -8.11% | 2.9% | -1.5% | 6.39% | -7.16% | -3.14% | -25.8% | -11.99% | 3.77% | -4.6% | -5.26% | -10.94% | 3.11% | 22.5% | 52.58% |
| FCF Growth % | -264.88% | 63.48% | -642.51% | 140.16% | -119.66% | 796.4% | 84.69% | -389.64% | 304.07% | -122.55% | 193.72% | -134.6% | 85.79% | -66.24% | -685.23% | 182.14% | 16.9% | 46.66% | -627.11% | -63.31% | 1.16% | - |
| FCF per Share | -0.23 | -0.06 | -0.16 | 0.03 | -0.08 | 0.39 | -0.06 | -0.39 | 0.14 | -0.07 | 0.32 | -0.35 | -0.15 | -1.11 | -0.69 | 0.14 | -0.17 | -0.21 | -0.38 | 0.14 | 0.74 | 0.82 |
| FCF Conversion (FCF/Net Income) | 0.63x | -1.80x | 0.77x | -1.67x | 0.45x | -6.10x | -0.38x | 1.80x | -0.77x | 0.01x | -1.32x | 0.42x | -0.01x | 0.64x | 0.53x | -0.46x | -1.79x | -13.21x | -3.34x | -2.06x | -0.76x | -0.72x |
| Interest Paid | 0 | 9.74M | 10.52M | 9.85M | 7.46M | 11.89M | 12.33M | 9.76M | 9.19M | 9.93M | 10.34M | 7.21M | 8.21M | 3.75M | 1.88M | 0 | 0 | 0 | 223K | 0 | 0 | 0 |
| Taxes Paid | 0 | 3.87M | 1.75M | 2.15M | 1.4M | 1.87M | 2.81M | 2.19M | 1.46M | 4.46M | 1.03M | 3.18M | 2.5M | 2M | 1.2M | 1.39M | 60K | 194K | 1.26M | 0 | 0 | 0 |
Capital intensity and liquidity
According to the provided financial data, the relationship between net income and operating cash flow is erratic, evidenced by a 2025Q4 OCF/NI ratio of -8.64, which suggests that reported earnings are frequently decoupled from the actual cash generation capabilities of the underlying radiotherapy business model.
The significant divergence between net income and operating cash flow indicates that non-cash items and working capital fluctuations are masking the true cash-generating potential of the firm. Investors should monitor this volatility, as it implies that the company's accounting earnings may not be a reliable proxy for its ability to fund operations internally.
As reported in the quarterly cash flow statements, Accuray has struggled to maintain positive free cash flow, with a -6.8% FCF margin in 2026Q3, reflecting a persistent inability to generate surplus cash after accounting for necessary capital expenditures and the company's high fixed-cost operating structure.
The consistent failure to achieve sustained positive free cash flow suggests that the business model remains structurally dependent on external financing or cash reserves to bridge operational gaps. This trend warrants further investigation into whether the company can reach a scale where cash inflows from service contracts consistently exceed the cash outflows required for product development.
Based on the reported figures, working capital changes have been highly inconsistent, ranging from a $21.1 million inflow in 2026Q1 to an $18.0 million outflow in 2025Q4, which suggests that the timing of customer payments and inventory management remains a primary source of cash flow instability.
These sharp swings in working capital appear to be driven by the lumpy nature of system installations and the associated milestone-based payment structures. Such variability makes it difficult to forecast short-term liquidity, as the company's cash position is highly sensitive to the timing of project completions and regulatory approvals.
Data from the last ten quarters indicates that Accuray maintains a low capital intensity, with CapEx/Revenue ratios frequently hovering near 1%, as noted in the 2026Q3 figure of 0.4%, suggesting that the company is not currently investing heavily in new physical manufacturing capacity.
While the low capital intensity may appear to preserve cash, it may also indicate a lack of investment in the infrastructure needed to drive future growth or improve manufacturing efficiency. Analysts should consider whether this low level of spending is sufficient to maintain the competitive relevance of the CyberKnife and Radixact platforms against better-capitalized peers.
Quick answers to the most common questions about buying ARAY stock.
Accuray Incorporated (ARAY) generated $2.9M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Accuray Incorporated (ARAY) reported negative free cash flow of $5.7M in 2025, indicating capital requirements exceeded cash from operations.
Accuray Incorporated (ARAY) spent $4.3M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.